Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000650027 | SCV000771864 | likely benign | Lipoic acid synthetase deficiency | 2023-12-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004020275 | SCV004899154 | uncertain significance | Inborn genetic diseases | 2021-03-24 | criteria provided, single submitter | clinical testing | The c.31A>T (p.T11S) alteration is located in exon 1 (coding exon 1) of the LIAS gene. This alteration results from a A to T substitution at nucleotide position 31, causing the threonine (T) at amino acid position 11 to be replaced by a serine (S). This alteration was detected in an individual with epilepsy; however, no additional phenotypic information was provided (Darbro, 2016). The p.T11S alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |